Using genetic tests to improve cancer care for all
Part of Cancer clinical trials.
This trial is testing whether a new system that connects genetic test results to your medical records can help reduce healthcare gaps for people with advanced cancer. It may help your doctor better personalize your treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have advanced cancer that is newly diagnosed, came back, didn't respond to treatment, spread, or is a high-grade type.
- Your doctor recommends a special genetic test (comprehensive genomic profile) based on standard guidelines.
- You are 18 years or older.
- You haven't already had this genetic test done for your current cancer situation.
- You want to explore additional treatment options.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special program led by oncology nurses can help more people with solid tumor cancers get genetic testing. If you are starting a new treatment and have not had genetic testing before, this program may help you learn about your cancer risks and treatment options.
This trial investigates genetic testing (mutational profiling) in people with various advanced cancers. It aims to understand how these tests can guide more personalized treatment decisions.
This trial studies how doing genetic (DNA) testing on your cancer helps doctors choose targeted treatments, and how those treatments affect outcomes. It is for adults whose cancer has not responded to the first standard treatment or who do not have curative options.
This study uses gene testing on stored tumor tissue (and a blood sample) to help doctors recommend treatment options that may fit your tumor’s specific changes. It may also help avoid certain medicines and share your de-identified data with other researchers.
This program gathers tumor samples to study their genetic and immune (immune-system) features across many types of advanced cancer. Your information and tumor testing may help researchers understand which tumor features are present and how they relate to cancer behavior.
This trial builds a large database using your existing tumor genetic test results (DNA and/or RNA). It may help researchers better understand advanced cancers and use gene patterns to guide future care.
Hear when a new Advanced Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.